Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique
NCT05517538 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2022-08-26
Summary
The aim of this study was to compare between the conventional palpation method of botulinum toxin type A injection and the electromyography-guided method using clinical parameters and electromyography analysis.
Conditions
- Glabellar Frown Lines
- Rhytides
- Wrinkle
- Facial Expression
Interventions
- DEVICE
-
Electromyography-Needle Intramuscular Drug guidance
EMG-guided needle neurotoxin injection
- DRUG
-
Botulinum toxin type A
Botulinum toxin type A injection into the Corrugator Supercilii muscle
Sponsors & Collaborators
-
Mohamed Hayder Oleish Salih
lead OTHER
Principal Investigators
-
Mohamed H Oleish, MB BCh · University of Alexandria
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-09
- Primary Completion
- 2021-12-02
- Completion
- 2021-12-15
Countries
- Egypt
Study Locations
More Related Trials
-
Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT00694148 ·Status: COMPLETED ·Phase: PHASE3
-
Intraoral Injection of Trigger Points by Botox
NCT05673655 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection
NCT01688076 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain
NCT06814535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®
NCT03796351 ·Status: COMPLETED ·Phase: PHASE1
-
Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A
NCT00989768 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines
NCT02108158 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
NCT02261493 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines
NCT01391299 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Commercial Preparations of Botulinum Toxin Type A
NCT00959907 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines
NCT03806933 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals
NCT06941883 ·Status: COMPLETED
-
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
NCT02353871 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone
NCT01186835 ·Status: COMPLETED ·Phase: NA
-
Assessment of Botulinum Toxin Injection for Treatment of Temporomandibular Joint Dislocation
NCT05863286 ·Status: UNKNOWN ·Phase: NA
-
Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines
NCT04631588 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01485601 ·Status: COMPLETED ·Phase: PHASE2
-
Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
NCT05766683 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles
NCT02019004 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Injecting Lateral Pterygoid Muscle by Botulinum Toxin Type A With 2 Different Methods : 3D Guided Appliance and Electromyography (EMG) .
NCT06633445 ·Status: COMPLETED ·Phase: NA
-
Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis
NCT03048383 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
NCT01271452 ·Status: COMPLETED ·Phase: PHASE4
-
Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
NCT06448676 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty
NCT03047499 ·Status: UNKNOWN